Molecular Diagnostics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

SKU ID :MI-13209958 | Published Date: 04-Mar-2019 | No. of pages: 135
Table of Contents Chapter 1 Overview of Molecular Diagnostics 1.1 Definition of Molecular Diagnostics in This Report 1.2 Commercial Types of Molecular Diagnostics 1.2.1 PCR 1.2.2 DNA Sequencing 1.2.3 NGS 1.3 Downstream Application of Molecular Diagnostics 1.3.1 Infectious Disease (Hepatitis, HIV) 1.3.2 Oncology 1.3.3 Genetic Testing 1.4 Development History of Molecular Diagnostics 1.5 Market Status and Trend of Molecular Diagnostics 2013-2023 1.5.1 Global Molecular Diagnostics Market Status and Trend 2013-2023 1.5.2 Regional Molecular Diagnostics Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Molecular Diagnostics 2013-2017 2.2 Sales Market of Molecular Diagnostics by Regions 2.2.1 Sales Volume of Molecular Diagnostics by Regions 2.2.2 Sales Value of Molecular Diagnostics by Regions 2.3 Production Market of Molecular Diagnostics by Regions 2.4 Global Market Forecast of Molecular Diagnostics 2018-2023 2.4.1 Global Market Forecast of Molecular Diagnostics 2018-2023 2.4.2 Market Forecast of Molecular Diagnostics by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Molecular Diagnostics by Types 3.2 Sales Value of Molecular Diagnostics by Types 3.3 Market Forecast of Molecular Diagnostics by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Molecular Diagnostics by Downstream Industry 4.2 Global Market Forecast of Molecular Diagnostics by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Molecular Diagnostics Market Status by Countries 5.1.1 North America Molecular Diagnostics Sales by Countries (2013-2017) 5.1.2 North America Molecular Diagnostics Revenue by Countries (2013-2017) 5.1.3 United States Molecular Diagnostics Market Status (2013-2017) 5.1.4 Canada Molecular Diagnostics Market Status (2013-2017) 5.1.5 Mexico Molecular Diagnostics Market Status (2013-2017) 5.2 North America Molecular Diagnostics Market Status by Manufacturers 5.3 North America Molecular Diagnostics Market Status by Type (2013-2017) 5.3.1 North America Molecular Diagnostics Sales by Type (2013-2017) 5.3.2 North America Molecular Diagnostics Revenue by Type (2013-2017) 5.4 North America Molecular Diagnostics Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Molecular Diagnostics Market Status by Countries 6.1.1 Europe Molecular Diagnostics Sales by Countries (2013-2017) 6.1.2 Europe Molecular Diagnostics Revenue by Countries (2013-2017) 6.1.3 Germany Molecular Diagnostics Market Status (2013-2017) 6.1.4 UK Molecular Diagnostics Market Status (2013-2017) 6.1.5 France Molecular Diagnostics Market Status (2013-2017) 6.1.6 Italy Molecular Diagnostics Market Status (2013-2017) 6.1.7 Russia Molecular Diagnostics Market Status (2013-2017) 6.1.8 Spain Molecular Diagnostics Market Status (2013-2017) 6.1.9 Benelux Molecular Diagnostics Market Status (2013-2017) 6.2 Europe Molecular Diagnostics Market Status by Manufacturers 6.3 Europe Molecular Diagnostics Market Status by Type (2013-2017) 6.3.1 Europe Molecular Diagnostics Sales by Type (2013-2017) 6.3.2 Europe Molecular Diagnostics Revenue by Type (2013-2017) 6.4 Europe Molecular Diagnostics Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Molecular Diagnostics Market Status by Countries 7.1.1 Asia Pacific Molecular Diagnostics Sales by Countries (2013-2017) 7.1.2 Asia Pacific Molecular Diagnostics Revenue by Countries (2013-2017) 7.1.3 China Molecular Diagnostics Market Status (2013-2017) 7.1.4 Japan Molecular Diagnostics Market Status (2013-2017) 7.1.5 India Molecular Diagnostics Market Status (2013-2017) 7.1.6 Southeast Asia Molecular Diagnostics Market Status (2013-2017) 7.1.7 Australia Molecular Diagnostics Market Status (2013-2017) 7.2 Asia Pacific Molecular Diagnostics Market Status by Manufacturers 7.3 Asia Pacific Molecular Diagnostics Market Status by Type (2013-2017) 7.3.1 Asia Pacific Molecular Diagnostics Sales by Type (2013-2017) 7.3.2 Asia Pacific Molecular Diagnostics Revenue by Type (2013-2017) 7.4 Asia Pacific Molecular Diagnostics Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Molecular Diagnostics Market Status by Countries 8.1.1 Latin America Molecular Diagnostics Sales by Countries (2013-2017) 8.1.2 Latin America Molecular Diagnostics Revenue by Countries (2013-2017) 8.1.3 Brazil Molecular Diagnostics Market Status (2013-2017) 8.1.4 Argentina Molecular Diagnostics Market Status (2013-2017) 8.1.5 Colombia Molecular Diagnostics Market Status (2013-2017) 8.2 Latin America Molecular Diagnostics Market Status by Manufacturers 8.3 Latin America Molecular Diagnostics Market Status by Type (2013-2017) 8.3.1 Latin America Molecular Diagnostics Sales by Type (2013-2017) 8.3.2 Latin America Molecular Diagnostics Revenue by Type (2013-2017) 8.4 Latin America Molecular Diagnostics Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Molecular Diagnostics Market Status by Countries 9.1.1 Middle East and Africa Molecular Diagnostics Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Molecular Diagnostics Revenue by Countries (2013-2017) 9.1.3 Middle East Molecular Diagnostics Market Status (2013-2017) 9.1.4 Africa Molecular Diagnostics Market Status (2013-2017) 9.2 Middle East and Africa Molecular Diagnostics Market Status by Manufacturers 9.3 Middle East and Africa Molecular Diagnostics Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Molecular Diagnostics Sales by Type (2013-2017) 9.3.2 Middle East and Africa Molecular Diagnostics Revenue by Type (2013-2017) 9.4 Middle East and Africa Molecular Diagnostics Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Molecular Diagnostics 10.1 Global Economy Situation and Trend Overview 10.2 Molecular Diagnostics Downstream Industry Situation and Trend Overview Chapter 11 Molecular Diagnostics Market Competition Status by Major Manufacturers 11.1 Production Volume of Molecular Diagnostics by Major Manufacturers 11.2 Production Value of Molecular Diagnostics by Major Manufacturers 11.3 Basic Information of Molecular Diagnostics by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Molecular Diagnostics Major Manufacturer 11.3.2 Employees and Revenue Level of Molecular Diagnostics Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Molecular Diagnostics Major Manufacturers Introduction and Market Data 12.1 ABBOTT LABORATORIES 12.1.1 Company profile 12.1.2 Representative Molecular Diagnostics Product 12.1.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ABBOTT LABORATORIES 12.2 AGILENT TECHNOLOGIES 12.2.1 Company profile 12.2.2 Representative Molecular Diagnostics Product 12.2.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of AGILENT TECHNOLOGIES 12.3 BECTON, DICKINSON AND COMPANY 12.3.1 Company profile 12.3.2 Representative Molecular Diagnostics Product 12.3.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BECTON, DICKINSON AND COMPANY 12.4 BIOMERIEUX 12.4.1 Company profile 12.4.2 Representative Molecular Diagnostics Product 12.4.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BIOMERIEUX 12.5 DANAHER 12.5.1 Company profile 12.5.2 Representative Molecular Diagnostics Product 12.5.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DANAHER 12.6 DIASORIN 12.6.1 Company profile 12.6.2 Representative Molecular Diagnostics Product 12.6.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DIASORIN 12.7 GRIFOLS 12.7.1 Company profile 12.7.2 Representative Molecular Diagnostics Product 12.7.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of GRIFOLS 12.8 HOLOGIC 12.8.1 Company profile 12.8.2 Representative Molecular Diagnostics Product 12.8.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of HOLOGIC 12.9 ILLUMINA 12.9.1 Company profile 12.9.2 Representative Molecular Diagnostics Product 12.9.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ILLUMINA 12.10 QIAGEN 12.10.1 Company profile 12.10.2 Representative Molecular Diagnostics Product 12.10.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN 12.11 ROCHE DIAGNOSTICS 12.11.1 Company profile 12.11.2 Representative Molecular Diagnostics Product 12.11.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ROCHE DIAGNOSTICS 12.12 SIEMENS 12.12.1 Company profile 12.12.2 Representative Molecular Diagnostics Product 12.12.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of SIEMENS 12.13 THERMO FISHER SCIENTIFIC 12.13.1 Company profile 12.13.2 Representative Molecular Diagnostics Product 12.13.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of THERMO FISHER SCIENTIFIC Chapter 13 Upstream and Downstream Market Analysis of Molecular Diagnostics 13.1 Industry Chain of Molecular Diagnostics 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Molecular Diagnostics 14.1 Cost Structure Analysis of Molecular Diagnostics 14.2 Raw Materials Cost Analysis of Molecular Diagnostics 14.3 Labor Cost Analysis of Molecular Diagnostics 14.4 Manufacturing Expenses Analysis of Molecular Diagnostics Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference
List of Tables Table Advantage and Disadvantage of PCR Table Advantage and Disadvantage of DNA Sequencing Table Advantage and Disadvantage of NGS Table Sales Volume of Molecular Diagnostics by Regions 2013-2017 Table Sales Value of Molecular Diagnostics by Regions 2013-2017 Table Production Volume of Molecular Diagnostics by Regions 2013-2017 Table Global Sales Volume of Molecular Diagnostics by Regions 2018-2023 Table Global Sales Value of Molecular Diagnostics by Regions 2018-2023 Table Global Production Volume of Molecular Diagnostics by Regions 2018-2023 Table Sales Volume of Molecular Diagnostics by Types 2013-2017 Table Sales Value of Molecular Diagnostics by Types 2013-2017 Table Sales Volume Forecast of Molecular Diagnostics by Types 2018-2023 Table Sales Value Forecast of Molecular Diagnostics by Types 2018-2023 Table Sales Volume of Molecular Diagnostics by Downstream Industry 2013-2017 Table Sales Volume Forecast of Molecular Diagnostics by Downstream Industry 2018-2023 Table North America Molecular Diagnostics Sales by Countries (2013-2017) Table North America Molecular Diagnostics Sales Share by Countries (2013-2017) Table North America Molecular Diagnostics Revenue by Countries (2013-2017) Table North America Molecular Diagnostics Revenue Market Share by Countries (2013-2017) Table North America Molecular Diagnostics Sales by Type (2013-2017) Table North America Molecular Diagnostics Sales Share by Type (2013-2017) Table North America Molecular Diagnostics Revenue by Type (2013-2017) Table North America Molecular Diagnostics Revenue Share by Type (2013-2017) Table North America Molecular Diagnostics Sales by Downstream Industry (2013-2017) Table North America Molecular Diagnostics Sales Share by Downstream Industry (2013-2017) Table Europe Molecular Diagnostics Sales by Countries (2013-2017) Table Europe Molecular Diagnostics Sales Share by Countries (2013-2017) Table Europe Molecular Diagnostics Revenue by Countries (2013-2017) Table Europe Molecular Diagnostics Revenue Market Share by Countries (2013-2017) Table Europe Molecular Diagnostics Sales by Type (2013-2017) Table Europe Molecular Diagnostics Sales Share by Type (2013-2017) Table Europe Molecular Diagnostics Revenue by Type (2013-2017) Table Europe Molecular Diagnostics Revenue Share by Type (2013-2017) Table Europe Molecular Diagnostics Sales by Downstream Industry (2013-2017) Table Europe Molecular Diagnostics Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Molecular Diagnostics Sales by Countries (2013-2017) Table Asia Pacific Molecular Diagnostics Sales Share by Countries (2013-2017) Table Asia Pacific Molecular Diagnostics Revenue by Countries (2013-2017) Table Asia Pacific Molecular Diagnostics Revenue Market Share by Countries (2013-2017) Table Asia Pacific Molecular Diagnostics Sales by Type (2013-2017) Table Asia Pacific Molecular Diagnostics Sales Share by Type (2013-2017) Table Asia Pacific Molecular Diagnostics Revenue by Type (2013-2017) Table Asia Pacific Molecular Diagnostics Revenue Share by Type (2013-2017) Table Asia Pacific Molecular Diagnostics Sales by Downstream Industry (2013-2017) Table Asia Pacific Molecular Diagnostics Sales Share by Downstream Industry (2013-2017) Table Latin America Molecular Diagnostics Sales by Countries (2013-2017) Table Latin America Molecular Diagnostics Sales Share by Countries (2013-2017) Table Latin America Molecular Diagnostics Revenue by Countries (2013-2017) Table Latin America Molecular Diagnostics Revenue Market Share by Countries (2013-2017) Table Latin America Molecular Diagnostics Sales by Type (2013-2017) Table Latin America Molecular Diagnostics Sales Share by Type (2013-2017) Table Latin America Molecular Diagnostics Revenue by Type (2013-2017) Table Latin America Molecular Diagnostics Revenue Share by Type (2013-2017) Table Latin America Molecular Diagnostics Sales by Downstream Industry (2013-2017) Table Latin America Molecular Diagnostics Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Molecular Diagnostics Sales by Regions (2013-2017) Table Middle East and Africa Molecular Diagnostics Sales Share by Regions (2013-2017) Table Middle East and Africa Molecular Diagnostics Revenue by Regions (2013-2017) Table Middle East and Africa Molecular Diagnostics Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Molecular Diagnostics Sales by Type (2013-2017) Table Middle East and Africa Molecular Diagnostics Sales Share by Type (2013-2017) Table Middle East and Africa Molecular Diagnostics Revenue by Type (2013-2017) Table Middle East and Africa Molecular Diagnostics Revenue Share by Type (2013-2017) Table Middle East and Africa Molecular Diagnostics Sales by Downstream Industry (2013-2017) Table Middle East and Africa Molecular Diagnostics Sales Share by Downstream Industry (2013-2017) Table Production Volume of Molecular Diagnostics by Major Manufacturers 2013-2017 Table Production Value of Molecular Diagnostics by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Molecular Diagnostics Major Manufacturer Table Employees and Revenue Level of Molecular Diagnostics Major Manufacturer Table Representative Molecular Diagnostics Product One of ABBOTT LABORATORIES Table Representative Molecular Diagnostics Product Two of ABBOTT LABORATORIES Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ABBOTT LABORATORIES 2013-2017 Table Representative Molecular Diagnostics Product One of AGILENT TECHNOLOGIES Table Representative Molecular Diagnostics Product Two of AGILENT TECHNOLOGIES Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of AGILENT TECHNOLOGIES 2013-2017 Table Representative Molecular Diagnostics Product One of BECTON, DICKINSON AND COMPANY Table Representative Molecular Diagnostics Product Two of BECTON, DICKINSON AND COMPANY Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BECTON, DICKINSON AND COMPANY 2013-2017 Table Representative Molecular Diagnostics Product One of BIOMERIEUX Table Representative Molecular Diagnostics Product Two of BIOMERIEUX Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BIOMERIEUX 2013-2017 Table Representative Molecular Diagnostics Product One of DANAHER Table Representative Molecular Diagnostics Product Two of DANAHER Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DANAHER 2013-2017 Table Representative Molecular Diagnostics Product One of DIASORIN Table Representative Molecular Diagnostics Product Two of DIASORIN Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DIASORIN 2013-2017 Table Representative Molecular Diagnostics Product One of GRIFOLS Table Representative Molecular Diagnostics Product Two of GRIFOLS Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of GRIFOLS 2013-2017 Table Representative Molecular Diagnostics Product One of HOLOGIC Table Representative Molecular Diagnostics Product Two of HOLOGIC Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of HOLOGIC 2013-2017 Table Representative Molecular Diagnostics Product One of ILLUMINA Table Representative Molecular Diagnostics Product Two of ILLUMINA Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ILLUMINA 2013-2017 Table Representative Molecular Diagnostics Product One of QIAGEN Table Representative Molecular Diagnostics Product Two of QIAGEN Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN 2013-2017 Table Representative Molecular Diagnostics Product One of ROCHE DIAGNOSTICS Table Representative Molecular Diagnostics Product Two of ROCHE DIAGNOSTICS Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ROCHE DIAGNOSTICS 2013-2017 Table Representative Molecular Diagnostics Product One of SIEMENS Table Representative Molecular Diagnostics Product Two of SIEMENS Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of SIEMENS 2013-2017 Table Representative Molecular Diagnostics Product One of THERMO FISHER SCIENTIFIC Table Representative Molecular Diagnostics Product Two of THERMO FISHER SCIENTIFIC Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of THERMO FISHER SCIENTIFIC 2013-2017
ABBOTT LABORATORIES AGILENT TECHNOLOGIES BECTON, DICKINSON AND COMPANY BIOMERIEUX DANAHER DIASORIN GRIFOLS HOLOGIC ILLUMINA QIAGEN ROCHE DIAGNOSTICS SIEMENS THERMO FISHER SCIENTIFIC
  • PRICE
  • $3680
    $6480

Our Clients